Cardiovascular adverse event reporting profile of tirzepatide: a real-world pharmacovigilance analysis of heart failure, arrhythmias, and ischemic events

Daqiu Chen, Zixun Wang, Zhanxiong Xie, Yixing Chen, Shunxiang Luo, Shanghua Xu

Open source

DOI
10.3389/fphar.2026.1785129
Published
2026-03-23
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1785129,
  title = {Cardiovascular adverse event reporting profile of tirzepatide: a real-world pharmacovigilance analysis of heart failure, arrhythmias, and ischemic events},
  author = {Daqiu Chen and Zixun Wang and Zhanxiong Xie and Yixing Chen and Shunxiang Luo and Shanghua Xu},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1785129},
  url = {https://doi.org/10.3389/fphar.2026.1785129}
}

RIS

TY  - JOUR
TI  - Cardiovascular adverse event reporting profile of tirzepatide: a real-world pharmacovigilance analysis of heart failure, arrhythmias, and ischemic events
AU  - Daqiu Chen
AU  - Zixun Wang
AU  - Zhanxiong Xie
AU  - Yixing Chen
AU  - Shunxiang Luo
AU  - Shanghua Xu
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1785129
UR  - https://doi.org/10.3389/fphar.2026.1785129
ER  - 

APA

Chen, D., Wang, Z., Xie, Z., Chen, Y., Luo, S., & Xu, S. (2026). Cardiovascular adverse event reporting profile of tirzepatide: a real-world pharmacovigilance analysis of heart failure, arrhythmias, and ischemic events. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1785129

Source records